AAAAAA
Results:
1-8
|
Results: 8
Authors:
Link, CD
Johnson, CJ
Fonte, V
Paupard, MC
Hall, DH
Styren, S
Mathis, CA
Klunk, WE
Citation: Cd. Link et al., Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34, NEUROBIOL A, 22(2), 2001, pp. 217-226
Authors:
Klunk, WE
Wang, YM
Huang, GF
Debnath, ML
Holt, DP
Mathis, CA
Citation: We. Klunk et al., Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain, LIFE SCI, 69(13), 2001, pp. 1471-1484
Authors:
Sukonick, DL
Pollock, BG
Sweet, RA
Mulsant, BH
Rosen, J
Klunk, WE
Kastango, KB
DeKosky, ST
Ferrell, RE
Citation: Dl. Sukonick et al., The 5-HTTPRS/*L polymorphism and aggressive behavior in Alzheimer disease, ARCH NEUROL, 58(9), 2001, pp. 1425-1428
Authors:
Sweet, RA
Hamilton, RL
Lopez, SL
Klunk, WE
Wisniewski, SR
Kaufer, DI
Healy, MT
DeKosky, ST
Citation: Ra. Sweet et al., Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features, INT PSYCHOG, 12(4), 2000, pp. 547-558
Authors:
Pettegrew, JW
Klunk, WE
Panchalingam, K
McClure, RJ
Stanley, JA
Citation: Jw. Pettegrew et al., Molecular insights into neurodevelopmental and neurodegenerative diseases, BRAIN RES B, 53(4), 2000, pp. 455-469
Authors:
Klunk, WE
Jacob, RF
Mason, RP
Citation: We. Klunk et al., Quantifying amyloid by Congo red spectral shift assay, METH ENZYM, 309, 1999, pp. 285-305
Authors:
Klunk, WE
Jacob, RF
Mason, RP
Citation: We. Klunk et al., Quantifying amyloid beta-peptide (A beta) aggregation using the Congo red A beta (CR-A beta) spectrophotometric assay, ANALYT BIOC, 266(1), 1999, pp. 66-76
Authors:
Klunk, WE
Panchalingam, K
McClure, RJ
Stanley, JA
Pettegrew, JW
Citation: We. Klunk et al., Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4, NEUROBIOL A, 19(6), 1998, pp. 511-515
Risultati:
1-8
|